Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease.
| Author | |
|---|---|
| Abstract |
:
Fibroblast growth factor-21 (FGF-21) is a metabolic regulator with beneficial effects on glucolipid metabolism. Since FGF-21 has lipid-lowering, anti-inflammatory and anti-oxidant properties, it may play a protective role against atherosclerosis. However, blood FGF-21 levels in coronary artery disease (CAD) or peripheral artery disease (PAD) have not been elucidated. |
| Year of Publication |
:
2018
|
| Journal |
:
Journal of atherosclerosis and thrombosis
|
| Date Published |
:
2018
|
| ISSN Number |
:
1340-3478
|
| URL |
:
https://dx.doi.org/10.5551/jat.41731
|
| DOI |
:
10.5551/jat.41731
|
| Short Title |
:
J Atheroscler Thromb
|
| Download citation |
